startup
Leyden Labs secures €40 million to develop intranasal protection against influenza and coronaviruses
Source:
eu-startups.com 1 min read
Share
You are reading a summary. The full content is hosted on eu-startups.com.
Following their selection for the EIC STEP Scale Up programme, Dutch BioTech startup Leyden Labs has raised €40 million to advance its nasal spray platform designed to protect against influenza and other respiratory viruses. The round brings together the European Innovation Council (EIC) Fund, Invest-NL, the Gates Foundation Strategic Investment Fund, ClavystBio, and others, with […] The post Leyden Labs secures €40 million to develop intranasal protection against influenza and coronaviruses appeared first on EU-Startups.
Read the full article on the original website
External link to eu-startups.com
Related Articles
startup
Sources: Uber halts plans to launch food delivery in five of the seven European countries it had targeted for expansion as it pursues a Delivery Hero takeover (Kieran Smith/Financial Times)
1 min read •
startup
India issues a notice to Telegram, asking it to curb the spread of pirated films and other copyrighted content, and seeks an action-taken report within 15 days (Sejal Sharma/Hindustan Times)
1 min read •
startup
Trump's God, guns and anticommunist Fourth of July
2 min read •